春立医疗股价涨5.03%

Company Overview - Spring Medical is a Chinese company primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants [1] - The company was established on February 12, 1998, and went public on December 30, 2021 [1] - Its main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [1] - The company's revenue composition is predominantly from medical device products at 99.89%, with a minor contribution of 0.11% from other sources [1] Market Performance - As of October 31, Spring Medical's stock price increased by 5.03%, reaching 26.50 CNY per share, with a trading volume of 26.14 million CNY and a turnover rate of 0.35% [1] - The total market capitalization of Spring Medical is 10.165 billion CNY [1] Shareholder Information - Among the top circulating shareholders, one fund from China Europe Fund, the China Europe Prosperity Selected Mixed A (020876), entered the top ten in the third quarter, holding 2.8326 million shares, which is 0.74% of the circulating shares [2] - The estimated floating profit for this fund today is approximately 3.5974 million CNY [2] Fund Performance - The China Europe Prosperity Selected Mixed A fund, managed by Zhang Xueming, has a total asset size of 6.741 billion CNY [3] - Since its inception, the fund has achieved a return of 70.66%, with a year-to-date return of 52.9% and a one-year return of 58.85% [2][3]